231 related articles for article (PubMed ID: 9220025)
1. Lovastatin decreases prolactin and growth hormone gene expression in GH4C1 cells through a cAMP dependent mechanism.
Lasa M; Chiloeches A; García N; Montes A; Toro MJ
Mol Cell Endocrinol; 1997 Jun; 130(1-2):93-100. PubMed ID: 9220025
[TBL] [Abstract][Full Text] [Related]
2. Induction of chinook salmon growth hormone promoter activity by the adenosine 3',5'-monophosphate (cAMP)-dependent pathway involves two cAMP-response elements with the CGTCA motif and the pituitary-specific transcription factor Pit-1.
Wong AO; Le Drean Y; Liu D; Hu ZZ; Du SJ; Hew CL
Endocrinology; 1996 May; 137(5):1775-84. PubMed ID: 8612514
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of pituitary-specific gene expression by insulin-like growth factor 1 in rat pituitary GH4C1 and GH3 cells.
Castillo AI; Aranda A
Endocrinology; 1997 Dec; 138(12):5442-51. PubMed ID: 9389530
[TBL] [Abstract][Full Text] [Related]
4. Effects of lovastatin on adenylyl cyclase activity and G proteins in GH4C1 cells.
Chiloeches A; Lasa M; Brihuega F; Montes A; Toro MJ
FEBS Lett; 1995 Mar; 361(1):46-50. PubMed ID: 7890038
[TBL] [Abstract][Full Text] [Related]
5. The homeodomain protein, Pit-1/GHF-1, is capable of binding to and activating cell-specific elements of both the growth hormone and prolactin gene promoters.
Fox SR; Jong MT; Casanova J; Ye ZS; Stanley F; Samuels HH
Mol Endocrinol; 1990 Jul; 4(7):1069-80. PubMed ID: 2284007
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional effects in GH3 cells of Gs alpha mutants associated with human pituitary tumors: stimulation of adenosine 3',5'-monophosphate response element-binding protein-mediated transcription and of prolactin and growth hormone promoter activity via protein kinase A.
Gaiddon C; Mercken L; Bancroft C; Loeffler JP
Endocrinology; 1995 Oct; 136(10):4331-8. PubMed ID: 7664652
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide stimulates prolactin gene expression in a rat pituitary cell line.
Coleman DT; Bancroft C
Endocrinology; 1993 Dec; 133(6):2736-42. PubMed ID: 8243297
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active Gq-alpha stimulates prolactin promoter activity via a pathway involving Raf activity.
Tian J; Ma HW; Bancroft C
Mol Cell Endocrinol; 1995 Aug; 112(2):249-56. PubMed ID: 7489829
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase A-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone.
Coleman DT; Chen X; Sassaroli M; Bancroft C
Endocrinology; 1996 Apr; 137(4):1276-85. PubMed ID: 8625900
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mitogen-activated protein kinase in cyclic adenosine 3',5'-monophosphate-induced hormone gene expression in rat pituitary GH(3) cells.
Yonehara T; Kanasaki H; Yamamoto H; Fukunaga K; Miyazaki K; Miyamoto E
Endocrinology; 2001 Jul; 142(7):2811-9. PubMed ID: 11416000
[TBL] [Abstract][Full Text] [Related]
12. The turkey transcription factor Pit-1/GHF-1 can activate the turkey prolactin and growth hormone gene promoters in vitro but is not detectable in lactotrophs in vivo.
Weatherly KL; Ramesh R; Strange H; Waite KL; Storrie B; Proudman JA; Wong EA
Gen Comp Endocrinol; 2001 Sep; 123(3):244-53. PubMed ID: 11589626
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro regulation of pituitary transcription factor-1 (Pit-1) by changes in the hormone environment.
González-Parra S; Chowen JA; García-Segura LM; Argente J
Neuroendocrinology; 1996 Jan; 63(1):3-15. PubMed ID: 8839350
[TBL] [Abstract][Full Text] [Related]
14. β-Hydroxybutyric sodium salt inhibition of growth hormone and prolactin secretion via the cAMP/PKA/CREB and AMPK signaling pathways in dairy cow anterior pituitary cells.
Fu SP; Wang W; Liu BR; Yang HM; Ji H; Yang ZQ; Guo B; Liu JX; Wang JF
Int J Mol Sci; 2015 Feb; 16(2):4265-80. PubMed ID: 25690038
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for luteinizing hormone induction of growth hormone gene transcription in fish model: crosstalk of the cAMP/PKA pathway with MAPK-and PI3K-dependent cascades.
Sun C; He M; Ko WK; Wong AO
Mol Cell Endocrinol; 2014 Feb; 382(2):835-50. PubMed ID: 24161589
[TBL] [Abstract][Full Text] [Related]
16. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
17. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
18. Effect of pituitary adenylate cyclase-activating polypeptide 38 on growth hormone and prolactin expression.
Velkeniers B; Zheng L; Kazemzadeh M; Robberecht P; Vanhaelst L; Hooghe-Peters EL
J Endocrinol; 1994 Oct; 143(1):1-11. PubMed ID: 7964308
[TBL] [Abstract][Full Text] [Related]
19. Expression of constitutively active Gs alpha-subunits in GH3 pituitary cells stimulates prolactin promoter activity.
Tian J; Chen J; Bancroft C
J Biol Chem; 1994 Jan; 269(1):33-6. PubMed ID: 8276815
[TBL] [Abstract][Full Text] [Related]
20. GH mRNA levels are elevated by forskolin but not GH releasing hormone in GHRH receptor-expressing MtT/S somatotroph cell line.
Voss TC; Goldman LR; Seek SL; Miller TL; Mayo KE; Somogyvari-Vigh A; Arimura A; Hurley DL
Mol Cell Endocrinol; 2001 Feb; 172(1-2):125-34. PubMed ID: 11165046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
